OverviewSuggest Edit

E-Qure Corp. focuses on the development and commercialization of bioelectrical signal therapy (BST) devices in the United States. Its BST device uses patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure.
TypePublic
Founded2014
HQNew York, US
Websitee-qure.com

Locations

E-Qure is headquartered in
New York, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)1(-66%)

E-Qure Office Locations

E-Qure has an office in New York
New York, US (HQ)
20 W 64th St #39g
Show all (1)

E-Qure Financials and Metrics

E-Qure Revenue

USD

Net income (Q1, 2019)

(164.1k)

Market capitalization (8-Oct-2018)

1.4m

Cash (31-Mar-2019)

252.1k
E-Qure's current market capitalization is $1.4 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

General and administrative expense

1.1m628.7k1.6m

R&D expense

224.5k117.6k

Operating expense total

(1.2m)(853.2k)(2.0m)

EBIT

(1.7m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

General and administrative expense

12.6k23.8k39.5k180.3k206.1k209.1k189.8k141.2k105.8k82.3k1.5m120.5k

R&D expense

435.8k133.3k132.8k39.3k26.2k4.9k9.9k7.4k43.6k

Operating expense total

12.6k23.8k(21.1m)(616.1k)339.4k341.9k229.0k167.4k110.7k92.2k1.5m164.1k

EBIT

(23.8k)(39.5k)(616.1k)(339.4k)(167.4k)
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

76.5k880.6k293.0k11.0k390.5k

Accounts Receivable

62.8k

Current Assets

76.5k880.6k408.1k32.0k390.5k

Total Assets

76.5k880.6k408.1k95.3k395.4k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

968.052.8k2.1m1.5m1.1m1.0m705.1k630.1k436.6k67.3k15.7k3.3k12.2k538.3k252.1k

Current Assets

977.052.8k2.1m1.5m1.1m1.0m705.1k630.1k436.6k172.2k105.0k11.6k12.2k538.3k252.1k

Total Assets

977.052.8k2.1m1.5m1.1m1.0m705.1k630.1k436.6k172.2k105.0k75.0k68.6k556.9k252.1k

Accounts Payable

5.7k1.6k1.6k1.6k161.3k298.2k1.6k1.6k
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.2m)(1.1m)(973.8k)(853.2k)(2.0m)

Cash From Operating Activities

(75.3k)(666.2k)(587.7k)

Cash From Financing Activities

148.9k170.0k138.1k1.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(109.9k)(59.0k)(21.2m)(24.5m)(405.1k)(541.1k)(290.2k)(495.1k)(834.5k)(341.9k)(571.0k)(110.7k)(202.9k)(1.7m)(164.1k)

Cash From Operating Activities

(49.4k)(23.8k)(57.5k)(678.2k)(408.6k)(544.6k)(175.6k)(250.5k)(444.1k)(225.7k)(342.5k)

Cash From Financing Activities

47.5k2.1m2.1m170.0k170.0k57.2k18.0k52.6k1.9m
USDY, 2019

Financial Leverage

33.3 x
Show all financial metrics

E-Qure Online and Social Media Presence

Embed Graph

E-Qure Frequently Asked Questions

  • When was E-Qure founded?

    E-Qure was founded in 2014.

  • How many employees does E-Qure have?

    E-Qure has 1 employees.

  • Who are E-Qure competitors?

    Competitors of E-Qure include Elanix Biotechnologies , Acelity and Obalon Therapeutics.

  • Where is E-Qure headquarters?

    E-Qure headquarters is located at 20 W 64th St #39g, New York.

  • Where are E-Qure offices?

    E-Qure has an office in New York.

  • How many offices does E-Qure have?

    E-Qure has 1 office.